| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis
|
Zhu, Ying
|
|
|
151 |
C |
p. 94-105
|
artikel
|
| 2 |
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study
|
Curigliano, Giuseppe
|
|
|
151 |
C |
p. 49-62
|
artikel
|
| 3 |
A meta-analysis of the efficacy of vascularised lymph node transfer in reducing limb volume and cellulitis episodes in patients with cancer treatment-related lymphoedema
|
Ward, Joseph
|
|
|
151 |
C |
p. 233-244
|
artikel
|
| 4 |
Circulating Epstein–Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma
|
Chen, Fo-Ping
|
|
|
151 |
C |
p. 63-71
|
artikel
|
| 5 |
Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increased
|
Sattler, Elke C.
|
|
|
151 |
C |
p. 168-174
|
artikel
|
| 6 |
CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer
|
Rouanne, Mathieu
|
|
|
151 |
C |
p. 245-248
|
artikel
|
| 7 |
Design, organisation and impact of treatment optimisation studies in breast, lung and colorectal cancer: The experience of the European Organisation for Research and Treatment of Cancer
|
Saesen, Robbe
|
|
|
151 |
C |
p. 221-232
|
artikel
|
| 8 |
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
|
Keil, Felix
|
|
|
151 |
C |
p. 201-210
|
artikel
|
| 9 |
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
|
Bogatyrova, Olga
|
|
|
151 |
C |
p. 136-149
|
artikel
|
| 10 |
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis
|
Mori, Keiichiro
|
|
|
151 |
C |
p. 35-48
|
artikel
|
| 11 |
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study
|
Wainberg, Zev A.
|
|
|
151 |
C |
p. 14-24
|
artikel
|
| 12 |
Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report
|
Kim, Hee J.
|
|
|
151 |
C |
p. 190-200
|
artikel
|
| 13 |
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
|
Riedl, Jakob M.
|
|
|
151 |
C |
p. 3-13
|
artikel
|
| 14 |
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada
|
Gupta, Sumit
|
|
|
151 |
C |
p. 126-135
|
artikel
|
| 15 |
Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma
|
Zhu, Gongjian
|
|
|
151 |
C |
p. 25-34
|
artikel
|
| 16 |
Lurbinectedin for metastatic small-cell bladder carcinoma
|
Boudin, Laurys
|
|
|
151 |
C |
p. 1-2
|
artikel
|
| 17 |
No improvement in survival of older women with cervical cancer—A nationwide study
|
Wenzel, Hans H.B.
|
|
|
151 |
C |
p. 159-167
|
artikel
|
| 18 |
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) – RMS2005 study
|
Glosli, Heidi
|
|
|
151 |
C |
p. 84-93
|
artikel
|
| 19 |
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
|
Hompland, Ivar
|
|
|
151 |
C |
p. 150-158
|
artikel
|
| 20 |
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials
|
Gan, Chun L.
|
|
|
151 |
C |
p. 115-125
|
artikel
|
| 21 |
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
|
Mezquita, Laura
|
|
|
151 |
C |
p. 211-220
|
artikel
|
| 22 |
Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
|
Ikeda, Satoshi
|
|
|
151 |
C |
p. 249-251
|
artikel
|
| 23 |
Response to letter entitled: Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
|
Duchemann, Boris
|
|
|
151 |
C |
p. 252-253
|
artikel
|
| 24 |
Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma
|
Carril-Ajuria, Lucia
|
|
|
151 |
C |
p. 106-114
|
artikel
|
| 25 |
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
|
Eckert, Cornelia
|
|
|
151 |
C |
p. 175-189
|
artikel
|
| 26 |
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis
|
Versluis, Judith M.
|
|
|
151 |
C |
p. 72-83
|
artikel
|
Tijdschrift beschrijving